<?xml version='1.0' encoding='utf-8'?>
<document id="28964268"><sentence text="A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data."><entity charOffset="18-27" id="DDI-PubMed.28964268.s1.e0" text="ritonavir" /><entity charOffset="28-37" id="DDI-PubMed.28964268.s1.e1" text="darunavir" /><entity charOffset="43-55" id="DDI-PubMed.28964268.s1.e2" text="dolutegravir" /><pair ddi="false" e1="DDI-PubMed.28964268.s1.e0" e2="DDI-PubMed.28964268.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28964268.s1.e0" e2="DDI-PubMed.28964268.s1.e1" /><pair ddi="false" e1="DDI-PubMed.28964268.s1.e0" e2="DDI-PubMed.28964268.s1.e2" /><pair ddi="false" e1="DDI-PubMed.28964268.s1.e1" e2="DDI-PubMed.28964268.s1.e1" /><pair ddi="false" e1="DDI-PubMed.28964268.s1.e1" e2="DDI-PubMed.28964268.s1.e2" /></sentence><sentence text="Dolutegravir (DTG) plus darunavir/ritonavir (DRV/r) is a simple combination of drugs that has the best genetic barrier to HIV-1 resistance and may be fit for salvage therapy"><entity charOffset="0-12" id="DDI-PubMed.28964268.s2.e0" text="Dolutegravir" /><entity charOffset="14-17" id="DDI-PubMed.28964268.s2.e1" text="DTG" /><entity charOffset="24-33" id="DDI-PubMed.28964268.s2.e2" text="darunavir" /><entity charOffset="34-43" id="DDI-PubMed.28964268.s2.e3" text="ritonavir" /><pair ddi="false" e1="DDI-PubMed.28964268.s2.e0" e2="DDI-PubMed.28964268.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28964268.s2.e0" e2="DDI-PubMed.28964268.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28964268.s2.e0" e2="DDI-PubMed.28964268.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28964268.s2.e0" e2="DDI-PubMed.28964268.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28964268.s2.e1" e2="DDI-PubMed.28964268.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28964268.s2.e1" e2="DDI-PubMed.28964268.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28964268.s2.e1" e2="DDI-PubMed.28964268.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28964268.s2.e2" e2="DDI-PubMed.28964268.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28964268.s2.e2" e2="DDI-PubMed.28964268.s2.e3" /></sentence><sentence text="" /><sentence text="All HIV-1-infected subjects treated with DTG plus DRV/r between March 2014 and September 2015 in eight Italian centres were included in the analysis"><entity charOffset="41-49" id="DDI-PubMed.28964268.s4.e0" text="DTG" /></sentence><sentence text=" The main metabolic data, efficacy parameters and safety data routinely collected were provided" /><sentence text=" This observational study is aimed to assess the efficacy of such approach" /><sentence text=" The primary end-point was the proportion of subjects achieving or maintaining virologic suppression &lt;50 copies/mL at week 24" /><sentence text=" Secondary end points were maintaining virologic suppression in the follow-up (weeks 48 and 96) and safety" /><sentence text="" /><sentence text="One hundred and thirty subjects were followed for a median of 56 months" /><sentence text=" Reasons for switching were simplification (44" /><sentence text="6%), viral failure (30%), toxicity (16" /><sentence text="9%), non-adherence (4" /><sentence text="6%), persistent low-level viremia (3" /><sentence text="1%), and drug-drug interaction (0" /><sentence text="8%)" /><sentence text=" At baseline, 118 subjects had documented resistance to 1 to 5 antiretroviral classes while 12 had viral rebound at a time when genotypic tests were not yet available" /><sentence text=" Seventeen and 14 subjects took DRV/r and DTG twice daily, respectively"><entity charOffset="42-44" id="DDI-PubMed.28964268.s18.e0" text="DTG" /></sentence><sentence text=" One subject was lost to follow-up, one discontinued for liver enzymes' elevation, one died of illicit drug abuse and one of cancer-related complications" /><sentence text=" The proportion of subjects with ongoing HIV replication dropped from 40% to 6" /><sentence text="1%" /><sentence text=" Those with undetectable viral load increased from 38" /><sentence text="5% to 76" /><sentence text="2%" /><sentence text=" At week 48, 17" /><sentence text="7% had HIV RNA between 1 and 49 copies/mL" /><sentence text=" The number of subjects with altered serum glucose, creatinine, ALT, AST, total-, HDL- and LDL-cholesterol, triglycerides and MDRD &lt;90 mL/min decreased by week 48, while those having MDRD &lt;60 mL/min remained 4"><entity charOffset="43-50" id="DDI-PubMed.28964268.s27.e0" text="glucose" /><entity charOffset="52-62" id="DDI-PubMed.28964268.s27.e1" text="creatinine" /><entity charOffset="64-67" id="DDI-PubMed.28964268.s27.e2" text="ALT" /><entity charOffset="69-72" id="DDI-PubMed.28964268.s27.e3" text="AST" /><entity charOffset="74-80" id="DDI-PubMed.28964268.s27.e4" text="total-" /><entity charOffset="82-86" id="DDI-PubMed.28964268.s27.e5" text="HDL-" /><entity charOffset="91-106" id="DDI-PubMed.28964268.s27.e6" text="LDL-cholesterol" /><entity charOffset="108-121" id="DDI-PubMed.28964268.s27.e7" text="triglycerides" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e0" e2="DDI-PubMed.28964268.s27.e0" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e0" e2="DDI-PubMed.28964268.s27.e1" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e0" e2="DDI-PubMed.28964268.s27.e2" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e0" e2="DDI-PubMed.28964268.s27.e3" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e0" e2="DDI-PubMed.28964268.s27.e4" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e0" e2="DDI-PubMed.28964268.s27.e5" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e0" e2="DDI-PubMed.28964268.s27.e6" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e0" e2="DDI-PubMed.28964268.s27.e7" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e1" e2="DDI-PubMed.28964268.s27.e1" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e1" e2="DDI-PubMed.28964268.s27.e2" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e1" e2="DDI-PubMed.28964268.s27.e3" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e1" e2="DDI-PubMed.28964268.s27.e4" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e1" e2="DDI-PubMed.28964268.s27.e5" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e1" e2="DDI-PubMed.28964268.s27.e6" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e1" e2="DDI-PubMed.28964268.s27.e7" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e2" e2="DDI-PubMed.28964268.s27.e2" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e2" e2="DDI-PubMed.28964268.s27.e3" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e2" e2="DDI-PubMed.28964268.s27.e4" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e2" e2="DDI-PubMed.28964268.s27.e5" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e2" e2="DDI-PubMed.28964268.s27.e6" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e2" e2="DDI-PubMed.28964268.s27.e7" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e3" e2="DDI-PubMed.28964268.s27.e3" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e3" e2="DDI-PubMed.28964268.s27.e4" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e3" e2="DDI-PubMed.28964268.s27.e5" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e3" e2="DDI-PubMed.28964268.s27.e6" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e3" e2="DDI-PubMed.28964268.s27.e7" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e4" e2="DDI-PubMed.28964268.s27.e4" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e4" e2="DDI-PubMed.28964268.s27.e5" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e4" e2="DDI-PubMed.28964268.s27.e6" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e4" e2="DDI-PubMed.28964268.s27.e7" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e5" e2="DDI-PubMed.28964268.s27.e5" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e5" e2="DDI-PubMed.28964268.s27.e6" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e5" e2="DDI-PubMed.28964268.s27.e7" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e6" e2="DDI-PubMed.28964268.s27.e6" /><pair ddi="false" e1="DDI-PubMed.28964268.s27.e6" e2="DDI-PubMed.28964268.s27.e7" /></sentence><sentence text="6%" /><sentence text=" Overall 90/283 baseline laboratory alterations returned to normality" /><sentence text="" /><sentence text="Switching to DTG plus DRV/r proved to be safe, suppressing viral replication without metabolic impact"><entity charOffset="13-25" id="DDI-PubMed.28964268.s31.e0" text="DTG" /></sentence><sentence text="" /></document>